Banner
Sudden Death In Hypertrophic Cardiomyopathy - The Exercise Didn't Do It

Sudden death in patients with hypertrophic cardiomyopathy (HCM) is sometimes associated with exercise...

20 Cent School Intervention Stops Unhealthy Weight Gain In Children

Rome, Italy - 27 Aug 2016: A school intervention costing less than 20 cents per child has stopped...

USDA Microbiologist Warns Bacteria In Vaping Products May Be A Health Concern

You recently saw how a build-up of microbes in bagpipes recently doomed a Scottish man. That could...

Breast Milk Sugar May Protect Babies Against Group B Streptococcus

A type of sugar found naturally in some women's breast milk may protect new born babies from infection...

User picture.
News StaffRSS Feed of this column.

News Releases From All Over The World, Right To You... Read More »

Blogroll

Nivolumab has been approved since April 2016 as a checkpoint inhibitor for the treatment of adults with locally advanced or metastatic nonsquamous non-small-cell lung cancer (NSCLC) who have already undergone chemotherapy. In an early benefit assessment, the German Institute for Quality and Efficiency in Health Care (IQWiG) has now examined whether in these patients this monoclonal antibody offers advantages over the appropriate comparator therapy.

According to the findings, there is an indication of a major added benefit of nivolumab over docetaxel. An added benefit over the appropriate comparator therapy (best supportive care) is not proven in patients for whom treatment with docetaxel or similar drugs is not indicated.


Incidence rates of early prostate cancer have continued to drop since the U.S. Preventive Services Task Force recommendation against routine prostate-specific antigen (PSA) testing in all men, according to an article published online by JAMA Oncology.

The USPSTF recommendation was released in draft form in 2011 and in final form in 2012. A decline in early prostate cancer incidence rates from 2011 to 2012 has been previously reported.


A new study led by Dr. Manel Esteller, Director of the Epigenetics and Cancer Biology Program (PEBC) of Bellvitge Biomedical Research Institute (IDIBELL), ICREA researcher and Professor of Genetics at University of Barcelona (UB) discovers that colorectal tumors present epigenetic heterogeneity that relates to the clinical course of the disease. The paper describing this finding has been published in the journal Gastroenterology, the most prestigious in the field of digestive diseases and official organ of the American Society of Gastroenterology.


Kyoto, Japan -- Termites not only raid people's homes, but also the humble abodes of other happy termite couples.

In new research, Kyoto University scientists have found that male Japanese termites form homosexual couples when no females are around -- and when the chance arises, they take over a heterosexual couple's nest and kill the male so that one of them can mate with the now spouseless female. The research team's observations support a theory that homosexual couplings in invertebrates have evolutionary advantages.


The term "healthy obesity" has gained traction over the past 15 years, but scientists have recently questioned its very existence. A study published August 18 in Cell Reports provides further evidence against the notion of a healthy obese state, revealing that white fat tissue samples from obese individuals classified as either metabolically healthy or unhealthy actually show nearly identical, abnormal changes in gene expression in response to insulin stimulation.


Concerns over the Zika virus have focused on pregnant women due to mounting evidence that it causes brain abnormalities in developing fetuses. However, new research in mice from scientists at The Rockefeller University and La Jolla Institute for Allergy and Immunology suggests that certain adult brain cells may be vulnerable to infection as well. Among these are populations of cells that serve to replace lost or damaged neurons throughout adulthood, and are also thought to be critical to learning and memory.